Target Vessel Revascularization (TVR)
Showing 1 - 25 of >10,000
QBX Peripheral Balloon Expandable Stent System in Peripheral
Not yet recruiting
- Peripheral Arterial Disease
- QBX (5F/6F) Peripheral Balloon Expandable Stent System
-
Genk, Limburg, Belgium
- +3 more
Apr 4, 2023
Xience Skypoint Stents in Routine Clinical Practice
Not yet recruiting
- Coronary Artery Disease
- XIENCE Skypoint™ stent
-
Seoul, Korea, Republic ofAsan Medical Hospital
Aug 1, 2023
Coronary Artery Disease, Coronary Stenosis, Stent Restenosis Trial in Torino (Percutaneous coronary intervention with the
Recruiting
- Coronary Artery Disease
- +4 more
- Percutaneous coronary intervention with the following platforms: Orsiro; Mistent; BioMime; Supraflex Cruz
-
Torino, ItalyFabrizio D'Ascenzo
Jan 19, 2022
Coronary Artery Disease, Myocardial Infarction Trial (IVL with Shockwave C2+ 2Hz Coronary IVL Catheter)
Not yet recruiting
- Coronary Artery Disease
- Myocardial Infarction
- IVL with Shockwave C2+ 2Hz Coronary IVL Catheter
- (no location specified)
Jul 28, 2023
Coronary Artery Disease Trial in Washington (PCI with SELUTION SLR DCB, PCI with FDA approved "-limus" DES)
Not yet recruiting
- Coronary Artery Disease
- PCI with SELUTION SLR DCB
- PCI with FDA approved "-limus" DES
-
Washington, District of ColumbiaMedStar Washington Hospital Center
Jul 7, 2023
DynamX Bioadaptor Global Post-Market Registry: Clinical Trial of
Not yet recruiting
- Coronary Artery Disease
- DynamX Novolimus-eluting Coronary Bioadaptor System
- (no location specified)
Oct 6, 2023
Acute Coronary Syndrome, Percutaneous Coronary Intervention Trial in Seongnam (Genoss DES)
Recruiting
- Acute Coronary Syndrome
- Percutaneous Coronary Intervention
- Genoss DES
-
Seongnam, Gyeonggi-do, Korea, Republic ofSeoul National University Bundang Hospital
Oct 15, 2023
Rotational Atherectomy in Routine Clinical Practice
Recruiting
- Atherosclerosis, Coronary
- Coronary Stenosis
- Rotational atherectomy
-
Bucheon, Korea, Republic of
- +7 more
Dec 12, 2022
Coronary Artery Disease Trial in United Kingdom (BioMatrix Alpha)
Not yet recruiting
- Coronary Artery Disease
- BioMatrix Alpha
-
Birmingham, United Kingdom
- +5 more
Mar 23, 2023
CRUSTAL Study in China
Not yet recruiting
- Coronary Artery Disease
- Calcification
- Shockwave Coronary Intravascular Lithotripsy (IVL) catheter
-
Nanjing, Guanxi, ChinaThe First Affiliated Hospital of Guangxi Medical University
Apr 13, 2023
Ischemic Heart Disease, Acute Coronary Syndrome Trial in Bialystok
Active, not recruiting
- Ischemic Heart Disease
- Acute Coronary Syndrome
-
Białystok, PolandDepartment of Invasive Cardiology, Medical University of Bialyst
Mar 15, 2023
Coronary Artery Disease, Coronary Bifurcation Lesion Trial in Eindhoven (Hybrid DEB approach with drug-eluting balloon,
Not yet recruiting
- Coronary Artery Disease
- Coronary Bifurcation Lesion
- Hybrid DEB approach with drug-eluting balloon
- Two-stent strategy
-
Eindhoven, North- Brabant, NetherlandsCatharina Hospital
Feb 7, 2023
Coronary Restenosis Trial in Ostrava (sirolimus-eluting balloon (SEB) MagicTouch, paclitaxel-eluting balloon (PEB) Sequent
Completed
- Coronary Restenosis
- sirolimus-eluting balloon (SEB) MagicTouch
- paclitaxel-eluting balloon (PEB) Sequent Please
-
Ostrava, CzechiaCardiovascular Department of University Hospital
Dec 6, 2022
Coronary Artery Disease Trial in Taoyuan (Orsiro stent, Xience stent, Any drug-eluting stent)
Not yet recruiting
- Coronary Artery Disease
- Orsiro stent
- +2 more
-
Taoyuan, TaiwanLinkou Chang Gung Memorial Hospital
Jan 16, 2022
In-stent Restenosis Trial in Worldwide (Drug Eluting Balloon)
Active, not recruiting
- In-stent Restenosis
- Drug Eluting Balloon
-
Grenoble, France
- +8 more
Feb 7, 2023
RESOLUTE ONYX Post-Approval Study
Completed
- Coronary Artery Disease
- Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System
-
Huntsville, Alabama
- +27 more
Oct 25, 2022
Coronary Artery Disease, In-stent Restenosis Trial (CT-FFR, Usual Care)
Not yet recruiting
- Coronary Artery Disease
- In-stent Restenosis
- CT-FFR
- Usual Care
- (no location specified)
Nov 8, 2022
Coronary Artery Disease Trial in Qingdao (Promus PREMIERTM Everolimus-Eluting Platinum Chromium Coronary Stent System)
Active, not recruiting
- Coronary Artery Disease
- Promus PREMIERTM Everolimus-Eluting Platinum Chromium Coronary Stent System
-
Qingdao, Shandong, ChinaQiLu Hospital of ShanDong University
Jul 8, 2022
Ischemic Heart Disease, Stenotic Coronary Lesion, Cardiovascular Diseases Trial in Shenyang, Beijing (Resolute Onyx™
Active, not recruiting
- Ischemic Heart Disease
- +4 more
- Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System
- Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System
-
Shenyang, Liaoning, China
- +1 more
Nov 2, 2022
Coronary Artery Disease Trial in Ho Chi Minh City (Percutaneous Coronary Intervention)
Recruiting
- Coronary Artery Disease
- Percutaneous Coronary Intervention
-
Ho Chi Minh City, VietnamUniversity Medical Center
Oct 1, 2023
Intravascular Ultrasound-Based Artificial Intelligence
Active, not recruiting
- Coronary Artery Disease
- percutaneous coronary intervention
-
Bucheon, Korea, Republic of
- +14 more
Apr 10, 2023
Coronary Disease, Coronary Artery Disease, Coronary Restenosis Trial in Lucerne (Impact of current PCI techniques/ devices in
Recruiting
- Coronary Disease
- +9 more
- Impact of current PCI techniques/ devices in complex coronary artery lesions
-
Lucerne, SwitzerlandLucerne Heart Centre
Oct 4, 2023
Deferred Revascularization Based on FFR and iFR Negative
Completed
- Coronary Artery Disease
- Fractional flow reserve, instantaneous wave-free Ratio
-
Karachi, Sindh, PakistanAga Khan University Hospital
Feb 13, 2022
ST-elevation Myocardial Infarction, Multivessel Coronary Disease Trial in Zurich (Staged complete PCI, Immediate complete PCI,
Active, not recruiting
- ST-elevation Myocardial Infarction
- Multivessel Coronary Disease
- Staged complete PCI
- +2 more
-
Zurich, SwitzerlandUniversity Hospital Zürich, Cardiology Department
Jun 13, 2022